These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 33412828)

  • 1. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in access to breast, colorectal, and cervical cancer screening programmes have intensified during the pandemic period. Findings of a health equity audit conducted by the Pavia Healthcare Protection Agency (Lombardy Region, Northern Italy).
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].
    Russo AG; Murtas R; Ballotari P; Cavalieri d'Oro L; Gambino ML; Fanetti AC; Maifredi G; Manzoni F; Sampietro G; Leoni O; Celata C; Cereda D; Deandrea S;
    Epidemiol Prev; 2024; 48(2):118-129. PubMed ID: 38770729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.
    Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S;
    Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses.
    Battisti F; Falini P; Gorini G; Sassoli de Bianchi P; Armaroli P; Giubilato P; Giorgi Rossi P; Zorzi M; Battagello J; Senore C; Zappa M; Mantellini P
    Ann Ist Super Sanita; 2022; 58(1):16-24. PubMed ID: 35324470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cervical and breast cancer screening among immigrant women resident in Italy].
    Francovich L; Di Napoli A; Giorgi Rossi P; Gargiulo L; Giordani B; Petrelli A
    Epidemiol Prev; 2017; 41(3-4 (Suppl 1)):18-25. PubMed ID: 28929723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
    JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management choices for better outcomes in oncologic screening programmes.
    Chiereghin A; Squillace L; Pizzi L; Sanna T; Bazzani C; Roti L; Mezzetti F
    Epidemiol Prev; 2024; 48(2):158-164. PubMed ID: 38770733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diffusion of screening programmes in Italy, year 2009.
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening in Italy: 2005 survey and 2006 preliminary data.
    Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
    Epidemiol Prev; 2008; 32(2 Suppl 1):7-22. PubMed ID: 18770992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diffusion of screening programmes in Italy, year 2010].
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to the three Italian screening in a sample of women (and men) in the Southern Italy.
    Genovese C; Squeri R; Alessi V; Conti A; D'Amato S; Mazzitelli F; Costa G; Squeri A
    Clin Ter; 2021; 171(1):e75-e79. PubMed ID: 33346333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Family Care Centres for health protection and promotion of individuals and communities: a reflection at the time of the Coronavirus].
    Lauria L; Lega I; Pizzi E; Donati S;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):374-379. PubMed ID: 33412832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social disparities in access to breast and cervical cancer screening by women living in Spain.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
    Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d'Aosta Oncological Network, Italy.
    Oderda M; Calleris G; Falcone M; Fasolis G; Muto G; Oderda G; Porpiglia F; Volpe A; Bertetto O; Gontero P
    Urologia; 2021 Feb; 88(1):3-8. PubMed ID: 33632087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.